Research News

A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan

PKD progression may be accelerated by commonly occurring renal crystal deposition that could be therapeutically controlled by relatively simple measures

Ultrasound elastography is a useful noninvasive biomarker to detect and quantify liver fibrosis and portal hypertension in children with ARPKD

Metabolomics in ADPKD: how plasma metabolites and lipids are associated with kidney function and kidney volume in hypertensive patients

Meta-analysis demonstrates that GFR slope might be a viable surrogate endpoint in clinical trials for CKD

Check out the agenda for this year’s Baltimore PKD Symposium on September 23, 2019.

Addressing the Need for Clinical Trial End Points in Autosomal Dominant Polycystic Kidney Disease: A Report From the Polycystic Kidney Disease Outcomes Consortium (PKDOC)

An ADPKD Patient’s View on Screening for Intracranial Aneurysms

The PKD Foundation collaborates with ASN to support the latest Jared J. Grantham Research Fellowship recipient Ken Sutha MD, PhD

New drug compound could tackle major life-limiting kidney disease

Molecular structure of the PKD protein complex finally solved

Developing a Research Mentorship Program: The American Society of Pediatric Nephrology's Experience

Urinary T cells may be a novel candidate marker of disease activity in ADPKD

Researchers have developed a new class of drugs to tackle a common hereditary kidney disease

Using the suPAR lab test to assess total kidney volume and patients at risk for rapid progression

The ASN Foundation for Kidney Research provides more than $3 million in funding for clinical and basic research for members at all stages of their careers

For additional research information contact us!

Phone: (800) 753-2873